ArticleChildren (Basel, Switzerland)2025
A Novel Approach to the Management of Children with Primary Nocturnal Enuresis.
Article in Children (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesPrimary nocturnal enuresis (PNE) is a common condition that adversely affects the quality of life of both children and their families. It is known to have a multifactorial pathogenesis. This study aimed to evaluate serum levels of 25-hydroxyvitamin D (25OHD), vitamin B12, folic acid, and ferritin in children diagnosed with PNE and to investigate the impact of correcting detected deficiencies on the number of wet nights.
methodsA total of 150 pediatric patients diagnosed with monosymptomatic primary nocturnal enuresis (PNE) who had previously undergone standard urotherapy without clinical improvement were included in this study. Serum levels of vitamin B12 and 25-hydroxyvitamin D (25OHD) were assessed, and patients with deficiencies were identified. Vitamin supplementation was administered to those with deficient/insufficient levels. The number of wet nights was recorded at monthly follow-up visits to monitor clinical response.
resultsOnly 14% of the 150 patients had no detectable vitamin deficiencies. A deficiency in serum vitamin B12 levels was observed in 78.6% of patients, while 41.3% had reduced 25-hydroxyvitamin D (25OHD) levels. Concurrent deficiencies in both 25OHD and vitamin B12 were detected in 34% of the patients. No folate deficiency was observed in any patient. Notably, vitamin supplementation alone resulted in successful enuresis management in 77.6% of the patients.
conclusionsA high prevalence of vitamin B12 and 25-hydroxyvitamin D (25OHD) deficiencies was identified among patients diagnosed with primary nocturnal enuresis (PNE). Significant improvements in nocturnal dryness were achieved solely through correction of these deficiencies, without the use of desmopressin therapy. These findings suggest that targeted vitamin supplementation may play a crucial role in enhancing the success rate of standard urotherapy in the management of PNE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.